Estimation of Nutritional Needs of Preterm Neonates Fed on Parenteral Nutrition and Effects on Body Weight Gain

NCT ID: NCT07236957

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2024-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This randomized controlled trial included 100 preterm and small for gestational age neonates. The study aimed to determine the optimal approach for estimating nutritional needs in parenteral nutrition (PN) with the assistance of a specialized clinical decision support system (CDSS). More specifically, nutrient estimations based on the neonates' actual birth weight were compared to those calculated using the weight corresponding to the 10th percentile of the growth curve. The effect on growth outcomes over the PN course was investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background: Parenteral nutrition (PN) plays a crucial role in providing nutritional support to premature and small for gestational age neonates.

Aim: In this randomized controlled study, we evaluated PN administration in preterm and small for gestational age neonates using the corrected weight estimated at the 10th percentile of the growth curve, as guided by a clinical decision support system (CDSS).

Methods: A total of 100 preterm neonates were randomly assigned to either the Control group (n = 50) or the Intervention group (n = 50). Both groups received PN support using a specialized CDSS. In the Control group, the CDSS calculated the PN regimen based on the actual birth weight, whereas in the Intervention group, calculations were based on the corrected weight corresponding to the 10th percentile. Growth indicators (i.e., body weight, length, and head circumference) were measured at baseline and at the time of exclusive enteral feeding initiation. Blood samples were obtained at the last day of PN, after PN was ceased for 4 h and before oral feeding initiation. Electrolytes (sodium, potassium, calcium) and albumin concentrations, as well as red blood cells, white blood cells, haemoglobin and haematocrit were measured at the last day of PN.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Preterm Infant Development Preterm Infant Feeding Outcomes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A total of 100 preterm and small for gestational age neonates were randomly assigned to either the Control group (n = 50) or the Intervention group (n = 50). Both groups received parenteral nutrition (PN) supported by a specialized clinical decision support system. In the Control group, the PN regimen was based on the actual birth weight, whereas in the Intervention group, calculations were based on the corrected weight corresponding to the 10th percentile of the growth curve.
Primary Study Purpose

SCREENING

Blinding Strategy

SINGLE

Caregivers
The care providers who administered the parenteral (PN) solutions to the neonates were blinded to the identity of the PN solution.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nutrient estimation based on the actual weight (Control group)

In the Control group, the clinical decision support system was used to determine parenteral nutriton requirements.

Group Type SHAM_COMPARATOR

Control group

Intervention Type DIETARY_SUPPLEMENT

In the Control group, the parenteral nutrition regimen was estimiated based on the actual birth weight.

Nutrient estimations based on the corrected weight (Intervention group)

In the Intervention group, the clinical decision support system was used to determine parenteral nutrition requirements.

Group Type ACTIVE_COMPARATOR

Intervention Group

Intervention Type DIETARY_SUPPLEMENT

In the Intervention group, the macronutrient composition in the parenteral nutrition solutions was calculated based on the corrected weight corresponding to the 10th percentile of the growth curve.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Group

In the Intervention group, the macronutrient composition in the parenteral nutrition solutions was calculated based on the corrected weight corresponding to the 10th percentile of the growth curve.

Intervention Type DIETARY_SUPPLEMENT

Control group

In the Control group, the parenteral nutrition regimen was estimiated based on the actual birth weight.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* preterm neonates hospitalized in NICU and meeting the criteria for small for gestational age infants, i.e., neonates with birth weight under the 10th percentile,
* preterm neonates receiving exclusive parenteral nutrition, and
* parents' written consent for study participation.

Exclusion Criteria

* term birth newborns or newborns not fullfilling the criteria of small for gestational age infants,
* newborns with primary liver/bile duct disease,
* newborns receiving enteral nutrition, and/or
* neonates whose parents did not give a written consent to participate in the study
Minimum Eligible Age

1 Day

Maximum Eligible Age

1 Day

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Peloponnese

OTHER

Sponsor Role collaborator

Panos Papandreou

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Panos Papandreou

Head Pharmacologist

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Nutrition, IASO Hospital

Athens, Attica, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

References

Explore related publications, articles, or registry entries linked to this study.

Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013 Apr 20;13:59. doi: 10.1186/1471-2431-13-59.

Reference Type BACKGROUND
PMID: 23601190 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21-11-18AB

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Protein for Premies
NCT01773902 COMPLETED NA
Preemie Milk Analyser Validation Study
NCT06486194 NOT_YET_RECRUITING NA
Exclusive Enteral Nutrition in Preterm Neonates
NCT04337710 ACTIVE_NOT_RECRUITING NA
Preterm Infant Growth
NCT01162798 COMPLETED NA